| Date Filed | Type | Description |
| 03/23/2023 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Exercised 31,055 options to buy
@ $3.22, valued at
$100k
|
|
| 02/02/2023 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Gifted 10,000 shares
@ $0
Gifted 5,000 shares
@ $0
Sold 100,000 shares
@ $10.38, valued at
$1M
Exercised 100,000 options to buy
@ $5.45, valued at
$545k
|
|
| 01/05/2023 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 121,452 shares
@ $0 |
|
| 01/04/2023 |
4/A
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 60,580 shares
@ $0 |
|
| 12/21/2022 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 127,500 shares
@ $0
Granted 595,000 options to buy
@ $10.63, valued at
$6.3M
|
|
| 12/19/2022 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 14,100 shares
@ $10.9, valued at
$153.7k
|
|
| 12/02/2022 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 214,917 shares
@ $13, valued at
$2.8M
Sold 82,656 shares
@ $12.8, valued at
$1.1M
Exercised 214,917 options to buy
@ $1.42, valued at
$305.2k
Exercised 82,656 options to buy
@ $1.42, valued at
$117.4k
|
|
| 09/02/2022 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 60,580 shares
@ $0 |
|
| 09/01/2022 |
4/A
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 21,054 restricted stock units
@ $0 |
|
| 06/16/2022 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 15,000 options to buy
@ $1.11, valued at
$16.7k
|
|
| 01/13/2022 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 184,000 shares
@ $15.04, valued at
$2.8M
Exercised 184,000 options to buy
@ $4.73, valued at
$870.3k
|
|
| 01/06/2022 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 21,504 restricted stock units
@ $0 |
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
| 01/05/2021 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 21,054 restricted stock units
@ $0 |
|
| 12/17/2020 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 134,278 shares
@ $8.32, valued at
$1.1M
Exercised 134,278 options to buy
@ $4.15, valued at
$557.3k
Granted 870,000 options to buy
@ $8.31, valued at
$7.2M
|
|
| 12/07/2020 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $5.45, valued at
$136.3k
Granted 157,250 options to buy
@ $3.23, valued at
$507.9k
|
|
| 06/16/2020 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 6,500 options to buy
@ $8.42, valued at
$54.7k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2019 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 25,000 options to buy
@ $1.96, valued at
$49k
|
|
| 01/03/2019 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,568 shares
@ $8.07, valued at
$28.8k
|
|
| 12/21/2018 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 675,000 options to buy
@ $7.06, valued at
$4.8M
|
|
| 12/06/2018 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 80,000 shares
@ $9.12, valued at
$729.6k
Exercised 80,000 options to buy
@ $1.2, valued at
$96k
|
|
| 11/13/2018 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Bought 10,000 shares
@ $4.56, valued at
$45.6k
|
|
| 06/18/2018 |
4
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 10,000 options to buy
@ $9.8, valued at
$98k
|
|
| 05/21/2018 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Exercised 70,427 options to buy
@ $1.42, valued at
$100k
|
|
| 03/02/2018 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 43,224 shares
@ $4.97, valued at
$214.8k
Exercised 56,949 options to buy
@ $3.26, valued at
$185.7k
|
|
| 01/23/2018 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,584 shares
@ $5.59, valued at
$53.6k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2017 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 300,000 options to buy
@ $5.04, valued at
$1.5M
|
|
|